Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo

被引：0
|
作者：
Zhiqiang Zhang
Chunling Ma
Peng Li
Min Wu
Shengnan Ye
Liwu Fu
Jianhua Xu
机构：
[1] Fujian Medical University,Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology
[2] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute
[3] The First Affiliated Hospital of Fujian Medical University,undefined
来源：
Cell Communication and Signaling | / 17卷
关键词：
FW-04-806; ABCB1 transporter; ABCG2 transporter; Multiple drug resistance; Molecular docking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo
    Zhang, Zhiqiang
    Ma, Chunling
    Li, Peng
    Wu, Min
    Ye, Shengnan
    Fu, Liwu
    Xu, Jianhua
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
  • [2] Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo
    Lin, Fan
    Hoogendijk, Lisette
    Buil, Levi
    Beijnen, Jos H.
    van Tellingen, Olaf
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 2059 - 2064
  • [3] Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
    Wu, Chung-Pu
    Hsiao, Sung-Han
    Wu, Yu-Shan
    DRUG RESISTANCE UPDATES, 2023, 71
  • [4] Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP)
    Yang, Danwen
    Kathawala, Rishil J.
    Chufan, Eduardo E.
    Patel, Atish
    Ambudkar, Suresh V.
    Chen, Zhe-Sheng
    Chen, Xiang
    FUTURE ONCOLOGY, 2014, 10 (11) : 1827 - 1841
  • [5] Lapatinib could reverse ABCB1 and ABCG2 mediated-multidrug resistance in Vitro, ex-vivo and in Vivo but increase exposure of chemotherapeutic agent
    Dai, Chun-ling
    Wang, Yan-sheng
    Tiwari, Amit
    Wu, Chung-pu
    Su, Xiao-dong
    Wang, Si-rong
    Liu, Dong-geng
    Ashby, Charles, Jr.
    Huang, Yan
    Robey, Robert
    Liang, Yong-ju
    Chen, Li-ming
    Shi, Cheng-jun
    Ambudkar, Suresh
    Chen, Zhe-sheng
    Fu, Liwu
    CANCER RESEARCH, 2009, 69
  • [6] Effect of the Adition of Metformin on the expression of Multidrug-Resistance Genes (ABCB1, ABCG2) in Acute Lymphoblastic Leukemia: In Vitro and In Vivo Study
    Penafiel, Christian Omar Ramos
    Carrillo, Irma Olarte
    Maldonado, Rafael Ceron
    Sanchez, Adrian Santoyo
    Sinco, Humberto Baldemar Castellanos
    Figueroa, Efreen Montano
    Garcia, Gloria Queipo
    Tovar, Adolfo Martinez
    BLOOD, 2016, 128 (22)
  • [7] Reversal of ABCG2-mediated multidrug resistance by tepotinib in vitro and in vivo
    Wu, Zhuoxun
    Teng, Qiu-Xu
    Yang, Yuqi
    Acharekar, Nikita
    Wang, Jing-Quan
    He, Min
    Yoganathan, Sabesan
    Lin, Jun
    Wang, Jian
    Chen, Zhe-Sheng
    CANCER RESEARCH, 2022, 82 (12)
  • [8] POLYMORPHISMS OF MULTIDRUG RESISTANCE TRANSPORTER (ABCG2 AND ABCB1) GENES IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA
    Andrikovics, H.
    Koszarska, M.
    Bors, A.
    Papp, N.
    Czifra, D.
    Csacsovszki, O.
    Batai, A.
    Adam, E.
    Kozma, A.
    Lovas, N.
    Sipos, A.
    Dolgos, J.
    Fekete, S.
    Remenyi, P.
    Sarkadi, B.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA, 2013, 98 : 402 - 402
  • [9] Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo
    Budagaga, Youssif
    Sabet, Ziba
    Zhang, Yu
    Novotna, Eva
    Hanke, Ivo
    Rozkos, Tomas
    Hofman, Jakub
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
  • [10] VKNG 1 reverses multidrug resistance by inhibiting ABCG2 mediated drug transport in vitro and in vivo
    Narayanan, Silpa
    Gujarati, Nehaben A.
    Teng, Qiuxu
    Wang, Jingquan
    Cai, Chao-Yun
    Yang, Yuqi
    Chintalapati, Anirudh Jaganna
    Korlipara, Vijaya L.
    Chen, Zhe-Sheng
    CANCER RESEARCH, 2020, 80 (16)
12345